China Neurology Devices Market Opportunities, Industry 2031
China Neurology Devices Market Opportunities, Industry 2031
Segments - China Neurology Devices Market by Types (Cerebrospinal Fluid Management Device, Interventional Neurology Device, Neurosurgery Device, Neurostimulation Device, and Others), End-users (Hospitals, Ambulatory Surgery Centers, and Neurology Clinics) and Country (China) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031.
Upcoming
| Report ID :HC-2451
| 4.6 Rating
| 74 Reviews
| 195 Pages
| Format :
Report Description
The China neurology devices market size was valued at USD 1.01 Billion in 2022 and is anticipated to reach USD 2.25 Billion by 2031, expanding at a CAGR of 9.3% during the forecast period, 2023 – 2031. The growth of the market is attributed to the increasing number of neurological diseases, rising investment in neuroscience equipment by private agents, and the growth of R&D in neuro therapies.
Neurological equipment helps in early detection of various neurological diseases to help prevent Alzheimer’s disease, major depression, spinal cord injury, acute ischemic stroke, traumatic brain injury, and other diseases. These devices represent minimally invasive based technology.
Neurological devices are usually used in complex neurological cases, such as acute ischemic stroke, and are recommended for minimally invasive treatment. Compared to drug thrombolysis, these devices have potential advantages, such as faster recanalization and lower bleeding risk.
The Covid-19 pandemic affected the demand and supply of China neurology devices market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
China Neurology Devices Market Trends, Drivers, Restraints, and Opportunities
- Increasing investment in pharmaceutical and biotechnology industry is anticipated to boost the market during the forecast period.
- Rapid growth of the healthcare industry due to increasing geriatric population is the major factors fueling the market during the forecast period.
- Growing demand for minimally invasive surgeries and improvement in healthcare infrastructure is projected to drive the market during forecast period.
- High cost of neurological treatments and devices is anticipated to restrict the market growth.
- Implementations of strict regulations by government on neurological devices act as major challenges that can hamper the market growth during the forecast period.
- R&D investment and technological advancement of neurological devices for easy and minimally invasive diagnosis of neurological disorders is expected to offer immense opportunities for the market players.
Scope of Neurology Devices Market Report
The report on the China neurology devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Neurology Devices Market - China Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Types (Cerebrospinal Fluid Management Device, Interventional Neurology Device, Neurosurgery Device, Neurostimulation Device, and Others), End-users (Hospitals, Ambulatory Surgery Centers, and Neurology Clinics) |
|
Country Scope |
China |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Abbott Laboratories; B. Braun Melsungen AG; Boston Scientific Corporation; Johnson and Johnson; Medtronic PLC; MicroPort Scientific; Nihon Kohden Corporation; Smith & Nephew plc; and Stryker Corporation. |
China Neurology Devices Market Segment Insights
The cerebrospinal fluid management device segment holds a major market share
Based on types, the China neurology devices market is segregated into cerebrospinal fluid management devices, interventional neurology devices, neurosurgery device, neurostimulation device, and others. The cerebrospinal fluid management device segment is anticipated to expand at a rapid pace. The CSF imbalance can cause an increase in intracranial pressure (ICP), which can cause a variety of symptoms. In recent years, there has been tremendous development in the diagnosis and treatment of neurological illnesses, which is projected to drive market the market during forecast period.
The hospitals segment is anticipated to expand at a substantial CAGR
Based on end users, the China neurology devices market is segregated into hospitals, ambulatory surgery centers, and neurology clinics. The hospital segment accounts for a significant share of the market. Growth of the market is attributed to increasing prevalence of neurological disorders and rapid advancement in neurology devices.
On the other hand, the ambulatory surgery centers segment is anticipated to expand at a rapid pace during the forecast period due to increasing inclination of patients for minimally invasive medical procedures, the increasing number of outpatient surgery centers in developed countries, and convenience of programming in these centers, professional clinical staff, increased productivity, and increased safety and efficiency.
Segments
The China neurology devices market is segmented on the basis of
Types
- Photoelectric
- Dual-sensor
- Ionization
End-users
- Hospitals
- Ambulatory Surgery Centers
- Neurology Clinics
Country
- China
Key Players
- Abbott Laboratories
- B. Braun Melsungen AG
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- MicroPort Scientific
- Nihon Kohden Corporation
- Smith & Nephew plc
- Stryker Corporation
Competitive Landscape
Major players competing in the China neurology devices market include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, MicroPort Scientific, Nihon Kohden Corporation, Smith & Nephew plc, and Stryker Corporation.
Some of these players are using several market strategies including mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
Frequently Asked Questions
Opportunities include increased R&D investment, technological advancements in minimally invasive devices, and improvements in healthcare infrastructure.
Major companies include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, MicroPort Scientific, Nihon Kohden Corporation, Smith & Nephew plc, and Stryker Corporation.
High costs of neurological treatments and devices, along with strict government regulations, are significant challenges that may restrict market growth.
The ambulatory surgery centers segment is anticipated to expand at a rapid pace due to the increasing preference for minimally invasive procedures and the rise in outpatient centers.
The cerebrospinal fluid management device segment holds a major market share and is expected to expand rapidly.
The main types include cerebrospinal fluid management devices, interventional neurology devices, neurosurgery devices, neurostimulation devices, and others.
The pandemic caused supply chain disruptions, production shutdowns, and a decline in market growth. However, the launch of vaccines is expected to aid market recovery.
Key growth drivers include the increasing number of neurological diseases, rising investment in neuroscience equipment, growth in R&D for neuro therapies, and the demand for minimally invasive surgeries.
The market is anticipated to reach USD 2.25 billion by 2031, expanding at a CAGR of 9.3% from 2023 to 2031.
The China neurology devices market was valued at USD 1.01 billion in 2022.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Neurology Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Neurology Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Neurology Devices Market - Supply Chain
4.5. Global Neurology Devices Market Forecast
4.5.1. Neurology Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Neurology Devices Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Neurology Devices Market Absolute $ Opportunity
5. Global Neurology Devices Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Neurology Devices Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Neurology Devices Demand Share Forecast, 2019-2026
6. North America Neurology Devices Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Neurology Devices Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Neurology Devices Demand Share Forecast, 2019-2026
7. Latin America Neurology Devices Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Neurology Devices Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Neurology Devices Demand Share Forecast, 2019-2026
8. Europe Neurology Devices Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Neurology Devices Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Neurology Devices Demand Share Forecast, 2019-2026
9. Asia Pacific Neurology Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Neurology Devices Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Neurology Devices Demand Share Forecast, 2019-2026
10. Middle East & Africa Neurology Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Neurology Devices Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Neurology Devices Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Neurology Devices Market: Market Share Analysis
11.2. Neurology Devices Distributors and Customers
11.3. Neurology Devices Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Abbott Laboratories
11.4.2. B. Braun Melsungen AG
11.4.3. Boston Scientific Corporation
11.4.4. Johnson and Johnson
11.4.5. Medtronic PLC
11.4.6. MicroPort Scientific
11.4.7. Nihon Kohden Corporation
Methodology
Related Reports
Some other reports from this category!
Our Clients
